Yüksel Ürun: Key goals post ESMO24
Yüksel Ürun shared a post on LinkedIn:
“Key goals post ESMO24
1.Integrate findings into practice
2.Improve treatment accessibility
3.Update treatment guidelines
4.Educate clinicians and patients
5.Focus on long-term outcomes
6.Foster global collaboration.”
“And impact on outcome of cancer patients.”
Source: Yüksel Ürun/LinkedIn and
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023